semaglutide weight loss treatment warminster pa drug reduces risk of adverse cardiovascular events by 20% among overweight, obese patients GLP-1 Weight Loss Injections Near

PlexusDx sources all compounded semaglutide from licensed 503A compounding pharmacies that conduct in-house stability testing and provide clear expiration dates on every vial

Patients experiencing persistent vomiting or diarrhea should be monitored for signs of dehydration and renal dysfunction, with appropriate fluid replacement and potentially temporary discontinuation of the medication if necessary

We provide clear, up-front pricing at your consultation and offer specials and financing to make treatment accessible

In 2014, Liraglutide became the first GLP-1RA medication to be introduced to the US market for treatment of obesity and weight management (12)